While decreased chemerin levels have been reported in HBV-associated HCC in Asian cohorts, increased expression in NAFLD-related and idiopathic HCC has been noted in European studies, despite consistent CMKLR1 downregulation across tumor types, potentially limiting downstream signaling [80]. The gene discussed is RARRES2; the disease is metabolic dysfunction-associated steatotic liver disease.